mRNAワクチン・治療薬の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global mRNA Vaccines & Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：MRC2012B0836 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、mRNAワクチン・治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。mRNAワクチン・治療薬の種類別市場規模（感染症ワクチン、癌ワクチン）、用途別市場規模（感染症、がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Moderna Therapeutics、eTheRNA、BioNTech、CureVac、In-Cell-Art、Translate Bio、Tiba Biotechnology、Argos Therapeutics、Sangamo Therapeutics、Ethris、 ・地域別グローバル市場分析 2015年-2020年 ・mRNAワクチン・治療薬の北米市場（アメリカ、カナダ、メキシコ） ・mRNAワクチン・治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・mRNAワクチン・治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・mRNAワクチン・治療薬の南米市場（ブラジル、アルゼンチン） ・mRNAワクチン・治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：感染症ワクチン、癌ワクチン ・用途別分析：感染症、がん、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global mRNA Vaccines & Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
mRNA Vaccines & Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, mRNA Vaccines & Therapeutics market has been segmented into:
Infectious Disease Vaccines
Cancer Vaccines

By Application, mRNA Vaccines & Therapeutics has been segmented into:
Infectious Disease
Cancer
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global mRNA Vaccines & Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level mRNA Vaccines & Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global mRNA Vaccines & Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the mRNA Vaccines & Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and mRNA Vaccines & Therapeutics Market Share Analysis
mRNA Vaccines & Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, mRNA Vaccines & Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the mRNA Vaccines & Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in mRNA Vaccines & Therapeutics are:
Moderna Therapeutics
eTheRNA
BioNTech
CureVac
In-Cell-Art
Translate Bio
Tiba Biotechnology
Argos Therapeutics
Sangamo Therapeutics
Ethris
Among other players domestic and global, mRNA Vaccines & Therapeutics market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

---

1 mRNA Vaccines & Therapeutics Market Overview
1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
1.2 Classification of mRNA Vaccines & Therapeutics by Type
1.2.1 Global mRNA Vaccines & Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type in 2019
1.2.3 Infectious Disease Vaccines
1.2.4 Cancer Vaccines
1.3 Global mRNA Vaccines & Therapeutics Market by Application
1.3.1 Overview: Global mRNA Vaccines & Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Global mRNA Vaccines & Therapeutics Market by Regions
1.4.1 Global mRNA Vaccines & Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of mRNA Vaccines & Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) mRNA Vaccines & Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) mRNA Vaccines & Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) mRNA Vaccines & Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) mRNA Vaccines & Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) mRNA Vaccines & Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Moderna Therapeutics
2.1.1 Moderna Therapeutics Details
2.1.2 Moderna Therapeutics Major Business
2.1.3 Moderna Therapeutics SWOT Analysis
2.1.4 Moderna Therapeutics Product and Services
2.1.5 Moderna Therapeutics mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 eTheRNA
2.2.1 eTheRNA Details
2.2.2 eTheRNA Major Business
2.2.3 eTheRNA SWOT Analysis
2.2.4 eTheRNA Product and Services
2.2.5 eTheRNA mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 BioNTech
2.3.1 BioNTech Details
2.3.2 BioNTech Major Business
2.3.3 BioNTech SWOT Analysis
2.3.4 BioNTech Product and Services
2.3.5 BioNTech mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 CureVac
2.4.1 CureVac Details
2.4.2 CureVac Major Business
2.4.3 CureVac SWOT Analysis
2.4.4 CureVac Product and Services
2.4.5 CureVac mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 In-Cell-Art
2.5.1 In-Cell-Art Details
2.5.2 In-Cell-Art Major Business
2.5.3 In-Cell-Art SWOT Analysis
2.5.4 In-Cell-Art Product and Services
2.5.5 In-Cell-Art mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Translate Bio
2.6.1 Translate Bio Details
2.6.2 Translate Bio Major Business
2.6.3 Translate Bio Product and Services
2.6.4 Translate Bio mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Tiba Biotechnology
2.7.1 Tiba Biotechnology Details
2.7.2 Tiba Biotechnology Major Business
2.7.3 Tiba Biotechnology Product and Services
2.7.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Argos Therapeutics
2.8.1 Argos Therapeutics Details
2.8.2 Argos Therapeutics Major Business
2.8.3 Argos Therapeutics Product and Services
2.8.4 Argos Therapeutics mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sangamo Therapeutics
2.9.1 Sangamo Therapeutics Details
2.9.2 Sangamo Therapeutics Major Business
2.9.3 Sangamo Therapeutics Product and Services
2.9.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Ethris
2.10.1 Ethris Details
2.10.2 Ethris Major Business
2.10.3 Ethris Product and Services
2.10.4 Ethris mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global mRNA Vaccines & Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 mRNA Vaccines & Therapeutics Players Market Share
3.2.2 Top 10 mRNA Vaccines & Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Regions
4.2 North America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
5 North America mRNA Vaccines & Therapeutics Revenue by Countries
5.1 North America mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020)
5.2 USA mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe mRNA Vaccines & Therapeutics Revenue by Countries
6.1 Europe mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020)
6.2 Germany mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Countries
7.1 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020)
7.2 China mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
8 South America mRNA Vaccines & Therapeutics Revenue by Countries
8.1 South America mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue mRNA Vaccines & Therapeutics by Countries
9.1 Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global mRNA Vaccines & Therapeutics Market Forecast by Type (2019-2024)
10.3 Infectious Disease Vaccines Revenue Growth Rate (2015-2025)
10.4 Cancer Vaccines Revenue Growth Rate (2015-2025)
11 Global mRNA Vaccines & Therapeutics Market Segment by Application
11.1 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2015-2020)
11.2 mRNA Vaccines & Therapeutics Market Forecast by Application (2019-2024)
11.3 Infectious Disease Revenue Growth (2015-2020)
11.4 Cancer Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global mRNA Vaccines & Therapeutics Market Size Forecast (2021-2025)
12.1 Global mRNA Vaccines & Therapeutics Market Size Forecast (2021-2025)
12.2 Global mRNA Vaccines & Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America mRNA Vaccines & Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe mRNA Vaccines & Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America mRNA Vaccines & Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global mRNA Vaccines & Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of mRNA Vaccines & Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global mRNA Vaccines & Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market mRNA Vaccines & Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global mRNA Vaccines & Therapeutics Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Moderna Therapeutics Corporate Information, Location and Competitors
Table 7. Moderna Therapeutics mRNA Vaccines & Therapeutics Major Business
Table 8. Moderna Therapeutics mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2017-2018)
Table 9. Moderna Therapeutics SWOT Analysis
Table 10. Moderna Therapeutics mRNA Vaccines & Therapeutics Product and Solutions
Table 11. Moderna Therapeutics mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. eTheRNA Corporate Information, Location and Competitors
Table 13. eTheRNA mRNA Vaccines & Therapeutics Major Business
Table 14. eTheRNA mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)
Table 15. eTheRNA SWOT Analysis
Table 16. eTheRNA mRNA Vaccines & Therapeutics Product and Solutions
Table 17. eTheRNA mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. BioNTech Corporate Information, Location and Competitors
Table 19. BioNTech mRNA Vaccines & Therapeutics Major Business
Table 20. BioNTech mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2017-2018)
Table 21. BioNTech SWOT Analysis
Table 22. BioNTech mRNA Vaccines & Therapeutics Product and Solutions
Table 23. BioNTech mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. CureVac Corporate Information, Location and Competitors
Table 25. CureVac mRNA Vaccines & Therapeutics Major Business
Table 26. CureVac mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2017-2018)
Table 27. CureVac SWOT Analysis
Table 28. CureVac mRNA Vaccines & Therapeutics Product and Solutions
Table 29. CureVac mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. In-Cell-Art Corporate Information, Location and Competitors
Table 31. In-Cell-Art mRNA Vaccines & Therapeutics Major Business
Table 32. In-Cell-Art mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2017-2018)
Table 33. In-Cell-Art SWOT Analysis
Table 34. In-Cell-Art mRNA Vaccines & Therapeutics Product and Solutions
Table 35. In-Cell-Art mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Translate Bio Corporate Information, Location and Competitors
Table 37. Translate Bio mRNA Vaccines & Therapeutics Major Business
Table 38. Translate Bio mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2017-2018)
Table 39. Translate Bio SWOT Analysis
Table 40. Translate Bio mRNA Vaccines & Therapeutics Product and Solutions
Table 41. Translate Bio mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Tiba Biotechnology Corporate Information, Location and Competitors
Table 43. Tiba Biotechnology mRNA Vaccines & Therapeutics Major Business
Table 44. Tiba Biotechnology mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2017-2018)
Table 45. Tiba Biotechnology SWOT Analysis
Table 46. Tiba Biotechnology mRNA Vaccines & Therapeutics Product and Solutions
Table 47. Tiba Biotechnology mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Argos Therapeutics Corporate Information, Location and Competitors
Table 49. Argos Therapeutics mRNA Vaccines & Therapeutics Major Business
Table 50. Argos Therapeutics mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2017-2018)
Table 51. Argos Therapeutics SWOT Analysis
Table 52. Argos Therapeutics mRNA Vaccines & Therapeutics Product and Solutions
Table 53. Argos Therapeutics mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Sangamo Therapeutics Corporate Information, Location and Competitors
Table 55. Sangamo Therapeutics mRNA Vaccines & Therapeutics Major Business
Table 56. Sangamo Therapeutics mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2017-2018)
Table 57. Sangamo Therapeutics SWOT Analysis
Table 58. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product and Solutions
Table 59. Sangamo Therapeutics mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Ethris Corporate Information, Location and Competitors
Table 61. Ethris mRNA Vaccines & Therapeutics Major Business
Table 62. Ethris mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2017-2018)
Table 63. Ethris SWOT Analysis
Table 64. Ethris mRNA Vaccines & Therapeutics Product and Solutions
Table 65. Ethris mRNA Vaccines & Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 67. Global mRNA Vaccines & Therapeutics Revenue Share by Players (2015-2020)
Table 68. Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 69. Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions (2015-2020)
Table 70. North America mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020)
Table 71. North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Table 72. Europe mRNA Vaccines & Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific mRNA Vaccines & Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 74. South America mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020)
Table 75. South America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa mRNA Vaccines & Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Table 78. Global mRNA Vaccines & Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 79. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2015-2020)
Table 80. Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2021-2025)
Table 81. Global mRNA Vaccines & Therapeutics Revenue by Application (2015-2020)
Table 82. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2015-2020)
Table 83. Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2021-2025)
Table 84. Global mRNA Vaccines & Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. mRNA Vaccines & Therapeutics Picture
Figure 2. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type in 2019
Figure 3. Infectious Disease Vaccines Picture
Figure 4. Cancer Vaccines Picture
Figure 5. mRNA Vaccines & Therapeutics Revenue Market Share by Application in 2019
Figure 6. Infectious Disease Picture
Figure 7. Cancer Picture
Figure 8. Other Picture
Figure 9. Global mRNA Vaccines & Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global mRNA Vaccines & Therapeutics Revenue Share by Players in 2019
Figure 17. Global Top 5 Players mRNA Vaccines & Therapeutics Revenue Market Share in 2019
Figure 18. Global Top 10 Players mRNA Vaccines & Therapeutics Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 22. Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2018
Figure 23. North America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 24. Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. South America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 29. North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2019
Figure 30. USA mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. Canada mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Mexico mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 34. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2019
Figure 35. Germany mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. UK mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. France mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. Russia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. Italy mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2019
Figure 42. China mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Japan mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Korea mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. India mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. South America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 48. South America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2019
Figure 49. Brazil mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. Argentina mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. UAE mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. Egypt mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. South Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2015-2020)
Figure 58. Global mRNA Vaccines & Therapeutics Revenue Share by Type in 2019
Figure 59. Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2021-2025)
Figure 60. Global Infectious Disease Vaccines Revenue Growth Rate (2015-2020)
Figure 61. Global Cancer Vaccines Revenue Growth Rate (2015-2020)
Figure 62. Global mRNA Vaccines & Therapeutics Revenue Share by Application (2015-2020)
Figure 63. Global mRNA Vaccines & Therapeutics Revenue Share by Application in 2019
Figure 64. Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2021-2025)
Figure 65. Global Infectious Disease Revenue Growth Rate (2015-2020)
Figure 66. Global Cancer Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global mRNA Vaccines & Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America mRNA Vaccines & Therapeutics Revenue Market Forecast (2021-2025)
Figure 72. Europe mRNA Vaccines & Therapeutics Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Forecast (2021-2025)
Figure 74. South America mRNA Vaccines & Therapeutics Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

---